PUBLISHER: The Business Research Company | PRODUCT CODE: 1810889
PUBLISHER: The Business Research Company | PRODUCT CODE: 1810889
eHealth 2.0 involves the incorporation of advanced digital technologies into healthcare to build a more personalized, participatory, and patient-focused system. Its goal is to enhance health outcomes by improving communication, supporting patient monitoring, empowering patient decision-making, and optimizing care delivery. This approach promotes a more efficient, connected, and innovative healthcare environment.
The primary types of eHealth 2.0 include telemedicine, electronic health records (EHRs), e-prescriptions, remote patient monitoring, mobile health (mHealth), health information exchange (HIE), and more. Telemedicine leverages telecommunications such as video calls or phone to provide remote, non-emergency healthcare services, increasing accessibility and convenience, particularly in underserved regions. It offers services including monitoring, diagnostics, and treatment, with key end users comprising healthcare providers, insurers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The eHealth 2.0 market research report is one of a series of new reports from The Business Research Company that provides eHealth 2.0 market statistics, including the eHealth 2.0 industry global market size, regional shares, competitors with the eHealth 2.0 market share, detailed eHealth 2.0 market segments, market trends, opportunities, and any further data you may need to thrive in the eHealth 2.0 industry. This eHealth 2.0 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The eHealth 2.0 market size has grown rapidly in recent years. It will grow from $382.43 billion in 2024 to $430.73 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historic period can be attributed to increasing awareness of digital health tools, greater adoption of wearable health devices, expanding government support for eHealth initiatives, enhanced integration of ICT in healthcare, and the rising popularity of teleconsultation platforms.
The eHealth 2.0 market size is expected to see rapid growth in the next few years. It will grow to $686.26 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth anticipated in the forecast period can be attributed to the rising adoption of AI in healthcare, increasing demand for personalized medicine, growing investments in digital health startups, expanded use of blockchain for health data security, and a stronger focus on patient-centric care. Key trends during this time include advancements in remote monitoring technologies, the development of virtual health assistants, innovations in mobile health app features, improvements in interoperability standards, and the emergence of predictive analytics in healthcare.
The growing demand for remote patient monitoring is expected to drive the expansion of the eHealth 2.0 market in the near future. Remote patient monitoring (RPM) employs digital tools to gather and transmit patient health information from outside traditional clinical environments, allowing for timely interventions and decreasing the frequency of hospital visits. The rising need for RPM is largely due to the increasing prevalence of chronic illnesses, as it enables continuous health monitoring, facilitates early intervention, and reduces hospital dependency. RPM supports eHealth 2.0 by providing real-time health data beyond clinical settings, which helps deliver personalized and preventive care. This technology offers prompt insights for early intervention, reduces hospital strain, and encourages greater patient engagement. For example, in August 2023, Vivalink, a US healthcare technology firm, reported that 81% of clinicians now use remote patient monitoring, a significant jump from 20% in 2021, marking a 305% increase. Additionally, 84% of current RPM users plan to increase their use of the technology in 2024. Hence, the increasing demand for remote patient monitoring is fueling growth in the eHealth 2.0 market.
Key players in the eHealth 2.0 market are focusing on developing sophisticated health monitoring platforms to improve patient engagement and promote proactive healthcare management. These health and fitness monitoring platforms are digital tools that continuously track vital signs, activity levels, and overall wellness, helping both users and healthcare providers manage health, set goals, and support preventive care decisions. For instance, in August 2024, Huawei Technologies Co., Ltd., a China-based health device provider, introduced the new HUAWEI TruSense System. This system aims to deliver more accurate, comprehensive, and real-time health insights through wearable devices. TruSense combines advanced sensors and algorithms to monitor over 60 health indicators, including heart rate, stress levels, emotional state, respiratory function, and calorie consumption, providing quicker and more detailed health reports than previous systems.
In February 2024, DarioHealth Corp., a US digital health company, acquired Twill Inc. for an undisclosed amount. This acquisition enables DarioHealth to integrate Twill's digital therapeutics and behavioral health solutions, broadening its digital health platform and enhancing its offerings for managing chronic conditions. Twill Inc. is a US-based firm specializing in AI-powered digital health solutions, including mental health and chronic disease support.
Major players in the ehealth 2.0 market are CVS Health, Optum Inc., International Business Machines Corporation, Oracle Corporation, Siemens Healthineers, GE Healthcare, Athenahealth, Teladoc Health, eClinicalWorks, Telecare Corporation, Veradigm, Doximity, American Well, Greenway Health, Tebra Technologies Inc., AdvancedMD, Doctor on Demand, Medisafe, AMD Global Telemedicine, and CompuMed Inc.
North America was the largest region in the eHealth 2.0 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in eHealth 2.0 report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eHealth 2.0 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The eHealth 2.0 market consists of revenues earned by entities by providing services such as clinical decision support systems, virtual health assistants, personal health records, healthcare analytics, predictive modeling, and online health communities and social health. The market value includes the value of related goods sold by the service provider or included within the service offering. The eHealth 2.0 market also includes sales of smart inhalers, connected pill dispensers, and biosensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
eHealth 2.0 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ehealth 2.0 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ehealth 2.0 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ehealth 2.0 market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.